Ethyl 2-Chloroacetoacetate CAS 609-15-4 Puritas >99.0% (GC) Febuxostat Intermedia Factory

Description:

Nomen chemicum: Ethyl 2-Chloroacetoacetate

CAS: 609-15-4

Puritas: >99.0% (GC)

Aspectus: Hyalina in luce Yellow Serena Liquid

Medium Febuxostat (CAS: 144060-53-7);

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ruifu Chemical Supple Febuxostat intermedia:
Febuxostat CAS 144060-53-7
Ethyl 2-Chloroacetoacetate CAS 609-15-4
4-Hydroxythiobenzamide CAS, 25984-63-8
Ethyl 2-(3-Cyano-4-Hydroxyphenyl) -4-Methyl-1,3-Thiazole-5-Carboxylate CAS 161798-02-3
Ethyl 2-(3-Cyano-4-Isobutoxyphenyl) -4-Methyl-5-Thiazolecarboxylate CAS 160844-75-7
Ethyl 2-(3-Formyl-4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-01-2
Ethyl 2-(3-Formyl-4-Isobutoxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161798-03-4
Ethyl 2-(4-Hydroxyphenyl) -4-Methylthiazole-5-Carboxylatus CAS 161797-99-5

Chemical Properties:

Nomen chemicum	Ethyl 2-Chloroacetoacetate
Synonyma	2-Chloroacetoacetic Acidum Ethyl Ester;Ethyl 2-Chloro-3-Oxobutyrate
CAS Number	609-15-4
CATTUS Number	RF-PI1854
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C6H9ClO3
M. Pondus	164.59
Liquescens punctum	-80℃
Ferveret	107℃/14 mmHg (lit.)
Density	1.19 g/mL ad 25℃(lit.)
Index refractivus	n20/D 1.441 (lit.)
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Hyalina in luce Yellow liquida liquida
Puritas / Analysis Methodus	>99.0% (GC)
1 H NMR Spectrum	Congruunt cum Structure
Totalis immunditias	<1.00%
Test Standard	Enterprise Standard
Consuetudinem	Medium Febuxostat (CAS: 144060-53-7);

Sarcina & Repono:

sarcina: Fluorinated Utrem, 25kg/ Ferocactus, vel secundum exigentiam elit

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

Ethyl 2-Chloroacetoacetate (CAS: 609-15-4) intermedium magni momenti est Febuxostat (CAS: 144060-53-7).Febuxostat xanthine oxidase inhibitor est, amet hyperuricemia tractabat (podagra).Est nova et efficax inhibitor selectivi oxydi xanthini non-purini.Oxidase Xanthine est clavis enzyme ad productionem acidi urici promovendam.Febuxosutan potest reducere acidi uric in sanguinem aegrorum cum hyperuricemia et podagra.Studia clinica docuerunt medicamentum tutum et efficax esse.Medicamentum per hepate metabolum est et in excretione renum non nititur.